Physician profile
Robert V Carida
NPI 1184729170
$19,324.08
in general payments reported to CMS, 2019-2025
45 companies · $2,316 in 2025
The $2,316 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,225 · 2020: $2,730 · 2021: $1,260 · 2022: $3,208 · 2023: $2,277 · 2024: $3,308 · 2025: $2,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,809 · Education: $74.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,808.75 |
| Education | $74.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $3,942.14 | 2019-2025 | Impella |
| Abbott Laboratories | $2,743.83 | 2019-2024 | Amplatzer Amulet, Aveir, Confirm Rx |
| Shockwave Medical, INC | $1,856.18 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $1,504.73 | 2019-2025 | Farapulse, Emblem Mri S-Icd, Crossboss |
| Terumo Medical Corporation | $1,164.03 | 2019-2025 | Optitorque, Metacross Otw, Glidewire |
| Penumbra, INC. | $670.12 | 2019-2025 | Indigo System, Penumbra System |
| Janssen Pharmaceuticals, INC | $618.26 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $597.67 | 2019-2025 | |
| Heartflow, INC. | $556.56 | 2019-2025 | Ffrct |
| Pfizer INC. | $529.29 | 2019-2025 | |
| Cardiva Medical, INC. | $488.92 | 2019-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 6/7f Vcs |
| Astrazeneca Pharmaceuticals LP | $486.30 | 2019-2025 | Farxiga |
| Medtronic, INC. | $433.64 | 2022-2025 | Abre, Mycarelink, Closurefast |
| Cardiovascular Systems INC. | $425.51 | 2019-2022 | |
| Edwards Lifesciences Corporation | $373.18 | 2019-2024 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $349.55 | 2020-2025 | Lifevest |
| Amgen INC. | $309.36 | 2021-2025 | Repatha, Repatha |
| Stryker Corporation | $240.97 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amarin Pharma, INC. | $190.84 | 2019-2021 | |
| Chiesi USA, INC. | $181.55 | 2019-2023 | Cleviprex |
| La Jolla Pharmaceutical Company | $122.31 | 2019 | |
| Atricure, INC. | $115.78 | 2019 | |
| Cardinal Health 200 LLC | $115.56 | 2019 | |
| Medtronic Vascular, INC. | $113.28 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $108.49 | 2019-2025 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $106.24 | 2023-2025 | Assure Wcd |
| Bard Peripheral Vascular, INC. | $102.62 | 2021 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $99.51 | 2019 | |
| Novo Nordisk INC | $95.24 | 2024-2025 | Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.90 | 2019 | |
| Merck Sharp & Dohme LLC | $88.91 | 2022-2023 | Verquvo |
| Biosense Webster, INC. | $87.64 | 2022-2024 | Carto 3 |
| Esperion Therapeutics, INC. | $81.41 | 2024-2025 | Nexletol |
| Ekos Corporation | $56.54 | 2019 | |
| Lsi Solutions INC | $51.45 | 2022 | |
| Zoll Circulation INC | $40.06 | 2023-2024 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Akcea Therapeutics, INC. | $36.04 | 2020 | |
| Biotronik INC. | $23.52 | 2024 | |
| Cvrx, INC. | $18.14 | 2024 | Barostim Neo System |
| Glaxosmithkline, LLC. | $17.86 | 2025 | Arexvy, Shingrix |
| Teleflex LLC | $17.42 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.66 | 2025 | |
| Medicure Pharma INC. | $14.86 | 2023 | Zypitamag |
| Asahi Intecc USA, INC. | $13.60 | 2020 | |
| Gilead Sciences, INC. | $11.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Carida listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.